Related Experiment Video
Updated: Mar 26, 2026

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
Published on: December 5, 2017
Inhibition of MMP-9 attenuates hypertensive cerebrovascular dysfunction in Dahl salt-sensitive rats
Anuradha Kalani1, Sathnur B Pushpakumar1, Jonathan C Vacek1
1Department of Physiology and Biophysics, School of Medicine, University of Louisville, 500 South Preston Street, Health Sciences Centre, A-1201, Louisville, KY, 40202, USA.
Insights
Inhibiting matrix metalloproteinase-9 (MMP-9) with GM6001 reduced blood pressure and protected the brain in hypertensive rats. This suggests MMP-9 is a key factor in hypertensive cerebropathy, offering a potential therapeutic target.
Area of Science:
- Neuroscience
- Cardiovascular Research
- Pharmacology
Background:
- Hypertensive cerebropathy involves brain swelling and blood-brain barrier damage, with unclear molecular causes.
- Matrix metalloproteinase-9 (MMP-9) is implicated in vascular disruption, but its role in hypertension-induced brain pathology requires further elucidation.
Purpose of the Study:
- To investigate the potential of inhibiting MMP-9 using GM6001 to mitigate hypertensive cerebropathy.
- To assess the effects of GM6001 on blood pressure, oxidative stress, and blood-brain barrier integrity in a rat model.
Main Methods:
- Dahl salt-sensitive rats were induced with hypertension via a high-salt diet and treated with GM6001 (MMP inhibitor) or vehicle.
- Evaluated blood pressure, MMP-9 expression and activity, oxidative/nitrosative stress markers, and tight junction proteins (TJPs) in brain tissues.
Main Results:
- GM6001 treatment significantly reduced mean blood pressure and MMP-9 levels in hypertensive rats.
- Inhibition of MMP-9 ameliorated oxidative/nitrosative stress and normalized tight junction proteins, indicating restored vascular integrity.
- GM6001 alleviated cerebral vascular MMP-9 expression and reduced overall oxidative/nitrosative stress markers.
Conclusions:
- Pharmacological inhibition of MMP-9 effectively attenuates high blood pressure and associated cerebrovascular pathology in hypertensive rats.
- MMP-9 inhibition represents a promising therapeutic strategy for managing hypertensive cerebropathy by preserving vascular integrity.
Abstract:
Hypertensive cerebropathy is a pathological condition associated with cerebral edema and disruption of the blood-brain barrier. However, the molecular pathways leading to this condition remains obscure. We hypothesize that MMP-9 inhibition can help reducing blood pressure and endothelial disruption associated with hypertensive cerebropathy. Dahl salt-sensitive (Dahl/SS) and Lewis rats were fed with high-salt diet for 6 weeks and then treated without and with GM6001 (MMP inhibitor). Treatment of GM6001 (1.2 mg/kg body weight) was administered through intraperitoneal injections on alternate days for 4 weeks. GM6001 non-administered groups were given vehicle (0.9% NaCl in water) treatment as control. Blood pressure was measured by tail-cuff method. The brain tissues were analyzed for oxidative/nitrosative stress, vascular MMP-9 expression, and tight junction proteins (TJPs). GM6001 treatment significantly reduced mean blood pressure in Dahl/SS rats which was significantly higher in vehicle-treated Dahl/SS rats. MMP-9 expression and activity was also considerably reduced in GM6001-treated Dahl/SS rats, which was otherwise notably increased in vehicle-treated Dahl/SS rats. Similarly MMP-9 expression in cerebral vessels of GM6001-treated Dahl/SS rats was also alleviated, as devised by immunohistochemistry analysis. Oxidative/nitrosative stress was significantly higher in vehicle-treated Dahl/SS rats as determined by biochemical estimations of malondialdehyde, nitrite, reactive oxygen species, and glutathione levels. RT-PCR and immunohistochemistry analysis further confirmed considerable alterations of TJPs in hypertensive rats. Interestingly, GM6001 treatment significantly ameliorated oxidative/nitrosative stress and TJPs, which suggest restoration of vascular integrity in Dahl/SS rats. These findings determined that pharmacological inhibition of MMP-9 in hypertensive Dahl-SS rats attenuate high blood pressure and hypertension-associated cerebrovascular pathology.
More Related Videos
07:12Evaluation of Cerebral Blood Flow Autoregulation in the Rat Using Laser Doppler Flowmetry
Published on: January 19, 2020
08:08Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
Published on: June 10, 2015
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Direct Renin Inhibitors
Hypertension II: Pathophysiology
Antihypertensive Drugs: Angiotensin II Receptor Blockers